Skip to main content
Sotirios Tsimikas, MD, Cardiology, San Diego, CA

SotiriosTsimikasMD

Cardiology • San Diego, CA

Interventional Cardiology

Professor, Medicine, UCSD School of Medicine

Join to view full profile

Dr. Tsimikas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tsimikas' full profile

Already have an account?

  • Office

    200 W Arbor Dr
    San Diego, CA 92103
    Phone+1 858-657-8530
    Fax+1 858-657-8021

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 1992 - 1996
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Internal Medicine, 1988 - 1991
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1991 - 2025
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Journal Articles

  • Lipoprotein(A) Reduction in Persons with Cardiovascular Disease  
    Sotirios Tsimikas, MD, The New England Journal of Medicine
  • Lipoprotein(A) Reduction in Persons with Cardiovascular Disease  
    Sotirios Tsimikas, MD, The New England Journal of Medicine
  • Lipoprotein(A) Reduction in Persons with Cardiovascular Disease  
    Sotirios Tsimikas, MD, The New England Journal of Medicine
  • Join now to see all

Authored Content

  • The Role of Lipoprotein(A) in Calcific AV Disease and Insights into Its Medical TherapiesApril 2020
  • The Role of Lipoprotein(A) in Calcific AV Disease and Insights into Its Medical TherapiesApril 2020
  • Lipoprotein(A) Reduction in Persons with Cardiovascular DiseaseJanuary 2020
  • PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes with a Human Antibody Detects Clinically Relevant AtherothrombosisJanuary 2018
  • Join now to see all

Press Mentions

  • JACC - Oxidized Phospholipids and Calcific Aortic Valvular Disease
    JACC - Oxidized Phospholipids and Calcific Aortic Valvular DiseaseNovember 20th, 2024
  • High Lp(A) Linked to ASCVD Risk Even When LDL Cholesterol Is Low
    High Lp(A) Linked to ASCVD Risk Even When LDL Cholesterol Is LowNovember 13th, 2024
  • How Lp(A) Can Help Improve ASCVD Risk Assessment
    How Lp(A) Can Help Improve ASCVD Risk AssessmentMarch 1st, 2022
  • Join now to see all

Professional Memberships

Dr. Sotirios Tsimikas, Dr. Sotirios Tsimikas, MD, Dr. S Tsimikas